Routine immunohistochemical staining for high-molecular weight cytokeratin 34-β and α-methylacyl CoA racemase (P504S) in postirradiation prostate biopsies-Reference-Cited by-同舟云学术

Routine immunohistochemical staining for high-molecular weight cytokeratin 34-β and α-methylacyl CoA racemase (P504S) in postirradiation prostate biopsies

Published:2005-12-09 Issue:2 Volume:19 Page:287-290
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Martens Mildred B,Keller Jeremy H

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800531.pdf

Reference5 articles.

1. Yang XJ, Laven B, Tretiakova M, et al. Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma. Urology 2003;62:282–286.

2. Beach R, Gown AM, de Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol 2002;26:1588–1596.

3. Evans AJ . Methylacyl CoA racemase (p504s): overview and potential uses in diagnostic pathology as applied to prostate needle biopsies. Am J Clin Pathol 2003;56:892–897.

4. Molinie V, Fromont G, Sibony M, et al. Diagnostic utility of a p63/α-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate. Mod Pathol 2004;17:1180–1190.

5. Yang XJ, Wu CL, Woda BA, et al. Expression of alpha methylacyl-CoA racemase (p504s) in atypical adenomatous hyperplasia of prostate. Am J Surg Pathol 2002;26:921–925.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoplasms of the Prostate;Urologic Surgical Pathology;2020

2. Nonneoplastic Diseases of the Prostate;Urologic Surgical Pathology;2020

3. Three‐dimensional architecture of common benign and precancerous prostate epithelial lesions;Histopathology;2019-04-21

4. Surveillance after prostate focal therapy;World Journal of Urology;2018-06-09

5. Modalités d’évaluation et résultats des traitements ablatifs dans le cancer de la prostate;Progrès en Urologie;2017-11